Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and ...
β-glucocerebrosidase (GCase) structure. The 3D structure of the GCase ...
Secreted human GCase from hGBA1-NPCs restored GCase deficiency in mouse ...
Insertion of GCase Trp side chains into the membrane. A, top, GCase ...
(A) Structure of glucosylceramide (GlcCer) and degradation by GCase to ...
The life cycle of GCase in and beyond the lysosome. AMRF: Action ...
Reported significant changes in the levels of GCase protein, GCase ...
Expression and activity of N370S and N370D. Activity of WT GCase (WT ...
GCase expression in hGBA-NPC-treated 9H/PS-NA mouse brains (A) Human ...
Interaction of GCase and deuterated -syn on the membrane probed by ...
Evaluation of GCase and related genes (A, C) Western blot showing ...
Effect of treatments on GCase activity in GBAKO-THP1 monocytes ...
GCase expression in control and GD osteoblasts and phenotypic rescue by ...
In vivo ␣ -syn-GCase interaction. A , immunoprecipitation of GCase with ...
GCase is targeted to mitochondria A Isolated mitochondria from the ...
GCase protein levels and activity are reduced in sporadic AD brain ...
GCase protein and activity in Cerezyme treated and untreated GBA1 ...
Reduced GCase activity in monocytes from patients with Parkinson’s ...
Mature WT GCase amino acid sequence highlighting the regions targeted ...
GCase structure and dynamics during the performed MD simulations. In ...
(a) GCase double-displacement mechanism acting on its natural substrate ...
siRNA knockdown of GCase in HEK293 cells. (a) Representative full ...
Gcase activator 2 | β-glucocerebrosidase activator | TargetMol
GCase double‐displacement mechanism for glucosylceramide hydrolysis ...
Characteristics of GCase potential binding sites. Described residues ...
Making a strong case for GCase – The Science of Parkinson's
A) A structure of GCase (PDB 1OGS) showing mutation sites linked to PD ...
GCase protein levels and activity in fibroblasts. Measurements were ...
Enhancement of both GCase activity and protein levels in an enriched ...
GCase translation in OF2 cells after rapamycin treatment a Diagram of ...
Interactions of LRRK2 and GCase in lysosome function. LRRK2 modulates ...
| GCase exists in lysosomes and in mitochondria and plays a significant ...
GCase protein level and activity in patient-derived fibroblasts. (A ...
Lower GCase Immunolabeling in FTD-GRN. We performed GCase... | Download ...
GT-02287, a clinical stage GCase enhancer
PFB-FDGlu | GCase Activity Assay | TargetMol
Frontiers | Live cell in situ lysosomal GCase activity correlates to ...
Effects of ambroxol treatment. (A-C) GCase protein levels and activity ...
GCase modulates mitochondrial CI integrity and activity in iPSC-derived ...
GCase modulator-1 | Glucosidase | TargetMol
Gcase activator 1 | Glucosidase | TargetMol
GCase deficiency causes retinal degeneration and behavioral deficits ...
Schematic representation of constructs used for targeting GCase to ...
GCase activity and long‐term risk of dementia in Parkinson’s disease ...
Compositions and methods for treatment of gcase related disease states ...
Lower Levels of Mature GCase Protein and Accumulation of Incompletely ...
PG9V mice exaggerated GCase activity reduction and substrate ...
Interrogating GCase Activity in Human Monocytes Isolated from Parkinson ...
DCI of GCase sites. (a) Scatter plot of all GCase residues with ...
Allosteric Modulation of GCase Enhances Lysosomal Activity and Reduces ...
Gain Therapeutics: The Case For GCase In Parkinson’s And Buyout ...
(PDF) In-vitro GCase Activity Assay v1
(PDF) In vitro GCase activity assay (total cell lysate) v1
Overall relationships between neuropathology, GCase activity, and lipid ...
Pharmaceuticals | Free Full-Text | GCase Enhancers: A Potential ...
Immunohistochemical detection of GCase in a number of subcortical ...
Ambroxol treatment increases GCase intensity per cell when compared to ...
Experimental design for in vivo efficacy study, GCase activity in mouse ...
Gcase activator 2 | CAS 2759897-35-1 | AbMole BioScience | Gcase ...
Gcase activator 2 | C21H24N4O2 | CID 155289224 - PubChem
(PDF) Gcase co-immunoprecipitation v1
Gcase activator 3 | C23H20N4O2 | CID 2527354 - PubChem
Modeling of mutation effect on GCase structure. (A) GCase structure ...
MR-Guided Focused Ultrasound + GCase for Parkinson's Disease Clinical ...
Gcase | PDF
Docking analysis of GCase with 40 drugs .pptx
Multivalent GCase Enhancers: Synthesis and Evaluation of Glyco-Gold ...
Relationship between glucocerebrosidase (GCase) and neurologic diseases ...
Purified GCase-BS molecules are fully functional. (A) Schematic of ...
GCase-BS proof of concept in vivo. | Download Scientific Diagram
Schematic illustration of the designed approach for β-GCase activity ...
Abbreviations GD: Gaucher disease; GCase: Acid β-glucosidase; GlcCer ...
Top 10 Biomarkers Powering Parkinson’s Research | CST Blog
Interaction surfaces for GCase-SapC complex identified by computational ...
3,4,5-Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase ...
GCase-BS lysosomal mode of action in vitro. | Download Scientific Diagram
Our Science - Congruence
Biochemical markers of glucocerebrosidase (GCase) deficiency in primary ...
GBA1 - Target in Neurodegenerative Diseases
gcase.in
G-CASE
Schematic representation of hydrogen bond interactions (red dashed ...
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels ...
Rehabilitating Mutant GCase: Chemistry & Biology
dnli-20241231
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in ...
Gain Therapeutics: GT-02287 Keeps Racking Up Good Results | Seeking Alpha
(PDF) Late‐onset Krabbe disease presenting as spastic paraplegia ...
Gain Therapeutics to Start Testing GCase-Targeted Drug in Patients with ...
A Fluorescence spectra (λem = 515 nm) of β-GCase assay with various ...
